Parabilis Medicines (PBLS) vs Viridian Therapeutics (VRDN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Parabilis Medicines is the larger company by market cap ($3.44 billion vs $3.40 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PBLS | VRDN |
|---|---|---|
| Share price | $27.44 | $29.96 |
| Market cap | $3.44B | $3.40B |
| 1-day change | -0.67% | -4.71% |
| YTD return | — | -3.73% |
| 1-year return | — | -1.25% |
| 5-year return | — | +63.72% |
| EPS (TTM) | $-3.62 | $-3.85 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $70.85M |
| Revenue growth (YoY) | — | +23359.93% |
| Net income (latest FY) | — | $-342.60M |
| Operating margin | — | -512.91% |
| Net margin | — | -483.57% |
| 52-week high | $42.49 | $34.29 |
| 52-week low | $22.66 | $13.18 |
| Distance from 52-week high | -35.42% | -12.63% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +49.42% | +42.72% |
| Average volume | 975.55K | 2.14M |
| Shares outstanding | 123.68M | 113.56M |
| Employees | 145 | 252 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Parabilis Medicines
PBLS stock →Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
About Viridian Therapeutics
VRDN stock →Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 252 employees
PBLS vs VRDN FAQ
Which is bigger, Parabilis Medicines or Viridian Therapeutics?
Parabilis Medicines (PBLS) is larger, with a market capitalization of $3.44B compared with $3.40B for Viridian Therapeutics (VRDN).
Are Parabilis Medicines and Viridian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.